Stock Price
12.28
Daily Change
1.15%
Yearly
-26.29%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Takeda 3,324.00 19.00 0.57% -7.44%
Eisai 6,042.00 61.00 1.02% -21.80%
Agios Pharmaceuticals 30.66 -0.38 -1.21% -35.80%
ALKERMES 24.95 -0.27 -1.07% 11.93%
Amgen 231.22 -0.09 -0.04% -8.26%
Astrazeneca 59.97 0.49 0.82% 14.11%
Baxter International 86.71 1.11 1.30% 8.37%
BioCryst Pharmaceuticals 14.37 -0.17 -1.17% 57.14%
Biogen 231.59 0.78 0.34% -14.26%
Bluebird Bio 7.25 -0.30 -3.97% -84.52%
Bristol-Myers Squibb 64.56 -0.16 -0.25% 0.59%
Cara Therapeutics 12.47 0.53 4.44% -34.30%
Dr.Reddys Laboratories 4,591.55 -93.40 -1.99% -9.12%
Esperion Therapeutics 3.96 0.23 6.03% -84.46%
Exelixis 17.34 0.26 1.52% -18.67%
Gilead Sciences 68.75 -0.33 -0.47% 2.64%
GlaxoSmithKline 1,624.00 -42.40 -2.54% 18.99%
Halozyme Therapeutics 34.21 0.46 1.36% -27.98%
Immunogen 5.96 0.12 2.05% -22.09%
Incyte Corp 75.74 0.96 1.28% -19.34%
Ionis Pharmaceuticals 30.32 0.20 0.66% -51.52%
Ironwood Pharmaceuticals 11.20 0.01 0.04% 9.11%
Karyopharm Therapeutics 8.01 0.55 7.37% -46.81%
Eli Lilly 245.13 0.08 0.03% 21.14%
MacroGenics 13.70 0.45 3.36% -38.67%
Merck & Co 81.21 -0.09 -0.10% 0.03%
Mirati Therapeutics 122.71 1.90 1.57% -42.37%
Neurocrine Biosciences 74.05 1.22 1.68% -35.61%
Nektar Therapeutics 12.28 0.14 1.15% -26.29%
Novartis 81.18 -0.28 -0.34% -5.17%
Pfizer 53.46 -0.08 -0.15% 46.55%
Roche Holding 365.25 -0.45 -0.12% 15.31%
Seattle Genetics 135.37 2.82 2.13% -27.13%
Sarepta Therapeutics 65.76 2.61 4.13% -32.15%
Teva Pharmaceutical Industries Ltd 2,744.00 -83.00 -2.94% -32.75%
Xencor 35.96 0.99 2.83% -25.25%

Indexes Price Day Year
NASDAQ 14557 217.14 1.51% 7.59%
US2000 2083 19.92 0.97% -2.74%
US400 2706 18.97 0.71% 10.30%

Nektar Therapeutics
Nektar Therapeutics is a biopharmaceutical company. The Company discovers and develops medicines in areas of unmet medical need. Its research and development pipeline of new investigational drugs includes treatments for cancer and autoimmune disease. It has research and development (R&D) pipeline of medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. It leverages its chemistry platform to discover and design new drug candidates. These drug candidates utilize its polymer conjugate technology platforms, which are designed to enable the development of new molecular entities. Its R&D pipeline includes Bempegaldesleukin (NKTR-214), NKTR-358, NKTR-262 and NKTR-255. It develops medicines designed to modulate the activity of key immune cells, such as cytotoxic T cells and Natural Killer (NK) cells, to increase their numbers and improve their function to recognize and attack cancer cells directly or indirectly.